<DOC>
	<DOCNO>NCT01119430</DOCNO>
	<brief_summary>The purpose study examine whether speed clinical antidepressant action fluoxetine accelerate administer DU125530 full 5-HT1A antagonist .</brief_summary>
	<brief_title>Fluoxetine Versus Fluoxetine Plus DU125530 Major Depressive Disorder</brief_title>
	<detailed_description>SSRI act block serotonin transporter ( 5-HT ) , increase availability serotonin synaptic cleft avert reuptake . The increment serotonin activate 5-HT1A presynaptic autoreceptors , result modulation release serotonin presynaptic neuron . It propose 5-HT1A receptor antagonism could accelerate clinical effect antidepressant prevent negative feedback.Preclinical data obtain selective 5-HT1A antagonist , pindolol , mice lack 5-HT1a receptor support hypothesis . Results partial antagonist ( pindolol ) conclusive accelerate SSRI . It reasonable call question whether total antagonism 5-HT1a receptor could imply rapid antidepressant response . To test hypothesis conduct double blind , randomise , control trial DU 123550 add fluoxetine 20 mg/day</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Consecutive eligible patient age 18 70 Diagnosis unipolar major depression use DSMIV criterion moderate severe symptom ( score e 18 Hamilton Depression Rating ScaleHDRS 17 item ) . There washout 1 week antidepressant drug ( specifically 28 day fluoxetine ) prior enter study . Written inform consent obtain participant . Concurrent psychiatric disorder ( DSM IV axis I , II cluster A B ) Failure respond drug treatment current depressive episode Previous resistance SSRIs antidepressant drug Suicide risk score e 3 HDRS . Participation drug trial within previous month Presence delusion hallucination History substance abuse ( include alcohol ) past three month Pregnancy lactation Organic brain disease history seizures Serious organic illness hypo hyperthyroidism , cardiac arrhythmia , asthma , diabetes mellitus . Myocardial infarction past 6 month Frequent severe allergic reaction Concomitant use psychotropic drug ( benzodiazepine allow ) , locker catecholaminedepleting agent Current structured psychotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>major depression</keyword>
	<keyword>DU 125530</keyword>
	<keyword>Treatment depression</keyword>
	<keyword>Latency antidepressant</keyword>
</DOC>